From target discovery to trial optimization, bfLEAP empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP delivers what others can’t: biologically grounded, composition-aware analytics that guide smarter therapeutic decisions BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug…
Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to stall momentum. As biopharmaceutical companies double down on innovation and patient-centric research, a new industry survey from studioID and TriNetX reveals widespread integration of RWD and AI in drug development…
Expands use of the Certara Pinnacle 21® (P21) enterprise software platform to optimize clinical data flows for speed and quality Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of the United States and Canada, that expands Merck’s use of the Certara…
The deal pairs San Juan, Puerto Rico site’s deep community ties, top-tier enrollment, and 90% retention with Headlands’ network-wide infrastructure and resources to accelerate clinical research Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of CMRCenter (CMRC), a high-performing clinical research site in San Juan, Puerto Rico. The deal expands Headlands’ footprint…
BioDlink convenes a peer advisory event bringing together biotech CEOs, MNC leaders and researchers to discuss innovation and collaboration strategies Integrated one-stop technology platform helps innovative biotech companies launch life-saving therapies with greater speed, scale, and efficiency BioDlink, a leading global CDMO, hosted its 2025 Peer Advisory Board on June 26, 2025, spotlighting China’s dynamic clinical trial and…
Powered by Causal AI and Real-Time Patient-Level Data and Analytics, the ClinOps Platform Enables Faster and Smarter Decision Making Across Trial Lifecycles PhaseV, a leader in AI/ML-driven clinical development, today announced the launch of the ClinOps platform, a next-generation solution designed to modernize clinical trial operations through precision-guided site selection and dynamic performance monitoring. Built on…
Sanofi, Recursion, and Velocity Clinical Research Executives Join Council as Founding Members to Guide Responsible AI Use in Clinical Research and Drive Tangible Improvements in Study Design and Operational Outcomes Advarra, the market leader in regulatory review and clinical research technology, today announced the launch of the Council for Responsible Use of AI in Clinical Trials….
Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company’s newly established Cambridge location, where he will establish a group…
LabConnect, a leading provider of global central laboratory and support services for clinical trials, has selected Microsoft Dynamics 365 Finance and Supply Chain, and also engaged Deloitte to transform its enterprise resource planning (ERP) platform. This initiative is designed to streamline LabConnect’s financial and business operations while enhancing financial reporting management in line with the…